SaengerP. Abnormal sex differentiation. J Paediatr1984; 104: 1–17.
2.
HaseltineFPOhnoS. Mechanisms of gonadal differentiation. Science1981; 211: 1272–7.
3.
Imperato-McGinleyJ. Sex differentiation, normal and abnormal. Curr Top Exp Endocrinol1983; 5: 231–307.
4.
JossoN. Physiology of sex differentiation. In: The Intersex Child, Paediatr Adolesc Endocrinol Vol. 8. Basel: Karger. 1981; 1–13.
5.
JostA. Problems of fetal endocrinology. The gonadal and hypophyseal hormones. Rec Progr Horm Res.1985; 8: 379–413.
6.
JostA. A new look at the mechanisms controlling sex differentiation in mammals. Johns Hopkins Med J1972; 130: 38–53.
7.
SiiteriPKWilsonJD. Testosterone formation and metabolism during male sexual differentiation on the human embryo. J Clin Endocrinol Metab1974; 38: 113–25.
8.
WilsonJDGriffinJEGeorgeFW, The role of gonadal steroids in sexual differentiation. Rec Progr Horm Res.1981; 37: 1–33.
9.
AndersonDC. Sex hormone binding globulin. Clin Endocrinol1974; 3: 69.
10.
O'BrienIADLewinIGO'HareJPCorrallRJM. Reversible male subfertility due to hyperthyroidism. Br Med J1982; 285: 691.
11.
JørgensonJVBennettPJohnsenSG. Reversible male subfertility due to hyperthyroidism. Br Med J1982; 285: 1206 (Letter).
12.
KirschnerMAZuckerIRJespersonDL. Ovarian and adrenal vein catheterisation studies in women with idiopathic hirsutism. In: JamesVHTSerioMGiustiG, eds. The Endocrine Function of the Ovary. New York: Academic Press, 1976; 443–56.
13.
RuddBT. Urinary 17-oxogenic and 17-oxosteroids: A case for deletion from the clinical chemistry repetoire. Ann Clin BioChem.1983; 20: 65–71.
14.
WinterJSDFaimanCReyesFI. Sexual endocrinology of fetal and perinatal life. In: AustinCREdwardsRG, eds. Mechanisms of Sexual Differentiation in Man and Animals. New York: Academic Press, 1981; 206–53.
15.
TapanainenJ. Hormonal changes during the perinatal period: Serum testosterone, some of its precursors and FSH and prolactin in pre-term and full-term male infant cord blood and during the first week of life. J Steroid BioChem.1983; 18: 13–18.
16.
WinterJSD. Hypothalamic-pituitary function in the fetus, and infant. Clin Endocrinol Metab1982; 11: 41–55.
17.
SizonenkoPC. Endocrinology in pre-adolescents and adolescents. Am J Dis Child1978; 132: 704–12.
18.
PangSLevineLSChowE, Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J Clin Endocrinol Metab1979; 48: 821–6.
19.
ForestMG. Pattern of the response of testosterone and its precursors to human chorionic gonadotropin stimulation in relation to age in infants and children. J Clin Endocrinol Metab1979; 49: 132–7.
20.
ForestMGDavidMLecogA, Kinetics of the hCG-induced steroidogenic response of the human testis. III. Studies in children of the plasma level of testosterone and hCG: Rationale for testicular stimulation test. Pediatr Res.1980; 14: 819–24.
21.
ForestMG. Control of the onset of puberty. In: CrosignaniPGRubinP, eds. Endocrinology of Human Infertility: New Aspects. New York: Academic Press, 1981; 265–305.
22.
JuddHL. Biorhythms of gonadotrophins and testicular hormone secretion. In: KriegerDT, ed. Endocrine Rhythms. New York: Raven Press, 1979; 299–324.
VermeulenA. The androgens. In: GrayCHJamesVHT, eds. Hormones in Blood, 3rd edn.London: Academic Press, 1979; 356–416.
25.
VermeulenAVerdonckL. Plasma androgen levels during the menstrual cycle. Am J Obstet Gynecol.1976; 125: 491–4.
26.
RebarRWYenSSC. Endocrine rhythms in gonadotrophins and ovarian steroids with reference to reproductive processes. In: KriegerDT. ed. Endocrine Rhythms. New York: Raven Press.1979; 259–97.
27.
NewMIDupontBPangS, Metabolic errors in adrenal steroidogenesis. Curr Top Exp Endocrinol1983; 5: 309–58.
WilsonJD. Sex hormones and sexual behaviour. N Engl J Med.1979; 300: 1269–70.
30.
Imperato-McGinleyJPetersonREGautierT, Male pseudohermaphroditism secondary to 5 α-reductase deficiency—a model for the role of adrogens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid BioChem.1979; 11: 637–45.
31.
SavageMO. Ambiguous genitalia, small genitalia and undescended testes. Clin Endocrinol Metab1982; 11: 127–58.
32.
HughesIA. Congenital and acquired disorders of the adrenal cortex. Clin Endocrinol Metab1982; 11: 89–125.
33.
WhartonBAScottPH. The newborn. In: ClaytonBERoundJM, eds. Chemical Pathology and the Sick Child. Oxford: Blackwell Scientific Publications, 1984; 7–72.
34.
MeikleAWNelsonDH. Androgens and glucocorticoids. In: DonaldRA, ed. Endocrine Disorders: A Guide to Diagnosis. London: Butterworths/Basel: Marcel Dekker, 1984; 351–70.
35.
PangSLevineLSChowDM, Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol1979; 11: 575–84.
ClaytonBEJenkinsPRoundJM. 11-oxygenation index in urine. In: Paediatric Chemical Pathology: Clinical Tests and Reference Ranges. Oxford: Blackwell Scientific Publication, 1980; 121.
38.
HonourJWAndersonJMShackletonCHL. Difficulties in the diagnosis of congenital adrenal hyperplasia in early infancy: The 11 β-hydroxylase defect. Acta Endocrinol1983; 103: 101–9.
39.
OttenBJWellenJJRijkenJCW, Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia. J Clin Endocrinol Metab1983; 57: 1150–4.
40.
GrantDBDillonMJAtherdanSM, Congenital adrenal hyperplasia: Renin and steroid values during treatment. Eur J Paediatr1977; 126: 89–96.
41.
HughesAI, Continuing need for mineralo-corticoid therapy in salt-losing congenital adrenal hyperplasia. Arch Dis Childhood1979; 54: 350–5.
42.
RiordanFAIWoodPNWakelinKBettsPClaytonBE. Blood spot 17 α-hydroxypro-gesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy. Lancet.1984; 1: 708–10.
43.
Korth-SchutzSVirdisRSaengerP, Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab1978; 46: 452–8.
44.
HughesIAReedGF. Salivary 17 α-hydroxyprogesterone and congenital adrenal hyperplasia. In: ReadFGRiad-FahmyDWalkerRFGriffithsK, eds. Immunoassays of Steroids in Saliva. Ninth Tenovus Workshop. Cardiff: Alpha Omega Publishing, 1984; 274–85.
RaiferJWalshPC. Mixed gonadal dysgenesis-dysgenetic male pseudohermaphroditism. In: The Intersex Child. Paediatr Adolesc Endocrinol Vol. 8, Basel: Karger, 1981; 105–15.
47.
Van NiekerkWA. True hermaphroditism. In: The Intersex Child. Paediatr Adolesc Endocrinol Vol. 8, Basel: Karger, 1981; 80–99.
48.
Van NiekerkWA. True hermaphroditism. An analytic review with a report of three new cases. Am J Obstet Gynecol.1976; 126: 890–907.
49.
SchwartzMImperato-McGinleyJPetersonRE, Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab1981; 53: 123–7.
50.
ForestMG. Errors of testosterone biosynthesis. In: The Intersex Child. Paediatr Adolesc Endocrinol Vol. 8, Basel: Karger, 1981; 133–55.
Imperato-McGinleyJPetersonREGautierT, Hormonal evaluation of a large kindred with complete androgen insensitivity: Evidence for secondary 5 α-reductase deficiency. J Clin Endocrinol Metab1982; 54: 931–41.
55.
Mauvais-JarvisPKuttenFMowszowiczI, Different aspects of 5 α-reductase deficiency in male pseudohermaphroditism and hypothyroidism. Clin Endocrinol1981; 14: 459–69.
KuttennFMowszowiczIWrightF, Male pseudohermaphroditism: A comparative study of one patient with 5 α-reductase deficiency and three patients with the complete form of testicular feminisation. J Clin Endocrinol Metab1979; 49: 861–5.
58.
Imperato-McGinleyJPetersonRELeshinM, Male pseudohermaphroditism: The natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity. J Clin Endocrinol Metab1980; 50: 15–22.
59.
GriffinJEWilsonJD. Studies on the pathogenesis of the incomplete forms of androgen resistance in man. J Clin Endocrinol Metab1977; 45: 1137–43.
60.
LeePAMazurTDanishR, Micropenis. I. Criteria, etiologies and classification. Johns Hopkins Med J1980; 146: 156–63.
61.
FeldmanKWSmithDW. Fetal phallic growth and penile standards for newborn male infants. J Paediatr1975; 86: 395–8.
62.
DanishRKLeePAMazurT, Micropenis. II. Hypogonadotrophic hypogonadism. Johns Hopkins Med J1980; 146: 177–84.
63.
LeePADanishRKMazurT, Micropenis. III. Primary hypogonadism, partial androgen insensitivity and idiopathic disorders. Johns Hopkins Med J1980; 147: 175–84.
64.
SpitzL. Maldescent of the testis. Arch Dis Child1983; 58: 847–8.
65.
AnoussakisCLiakakosDKiburisJ, Effect of surgical repair of cryptorchidism on endocrine testicular function. J Paediatr1983; 103: 919–921.
66.
GendrelDRogersMJobJC. Plasma gonadotropin and testosterone values in infants with cryptorchidism. J Paediatr1980; 97: 217–20.
67.
JobJCGendrelD. Endocrine aspects of cryptorchidism. Urol Clin N Am1982; 9: 353–60.
AndlerWClarHE. Hypothalamic function in patients with tumours of the pineal area. Helv Paediatr Acta1982; 37: 323–9.
70.
Korth-SchultzSLevineLSNewMI. Evidence for the adrenal source of androgens in precocious adrenarche. Acta Endocrinol1976, 82: 342–52.
71.
De LangeWESnoepMCDoorenbosH. The effect of LH-RH infusion on serum LH, FSH and testosterone in boys with advanced puberty, delayed puberty and hypogonadotrophic hypogonadism. Acta Endocrinol1978; 89: 209–16.
72.
CooperAJIsmailAAASmithCG, Androgen function in ‘Psychogenic’ and ‘Constitutional’ types of impotence. Br Med J1970; 3: 17–20.
73.
SparkRFWhiteRAConnollyPB. Impotence is not always psychogenic. JAMA1980; 243: 750–5.
74.
De MowbrayRR. Male hypogonadism, infertility and impotence. In: KeynesW MiloFowlerPBS, eds. Clinical Endocrinology. London: Wm Heinemann, 1984; 473–524.
75.
BatemanDN. Drugs and sexual function. Adv Drug React Bull1980; 85: 308–11.
76.
BuchananJFDavisLJ. Drug induced infertility. Drug Int Clin Parm1984; 18: 122–32.
77.
FranksSJacobsHSMartinN, Hyperprolactinaemia and impotence. Clin Endocrinol1978; 8: 277–87.
78.
LargeDMAndersonDC. Twenty-four hour profiles of circulating androgens and oestragens in male puberty with and without gynaecomastia. Clin Endocrinol1979; 11: 505–21.
79.
MooreDCSchlaepferLVPaunierL, Hormonal changes during puberty v. transient pubertal gynaecomastia: Abnormal androgen-oestrogen ratios. J Clin Endocrinol Metab1984; 58: 492–9.
80.
CarlsonHE. Gynaecomastia. N Engl J Med.1980; 303: 795–9.
81.
WilsonJDAimanJMacDonaldPC. The pathogenesis of gynaecomastia. Adv Int Med.1980; 25: 1–32
82.
BongiovanniAM. Acquired adrenal hyperplasia with special reference to 3 β-hydroxysteroid dehydrogenase. Fertil Steril1981; 35: 599–608.
83.
Imperato-McGinleyJPetersonREStollerR, Male psuedo-hermaphroditism secondary to 17 β-hydroxysteroid dehydrogenase deficiency: Gender role change with puberty. J Clin Endocrinol Metab1979; 43: 391–5.
84.
LarreaFBenavidesGScagliaH, Gynaecomastia as a familial incomplete male pseudohermaphroditism Type I: A limited androgen resistance syndrome. J Clin Endocrinol Metab1978; 46: 961–70.
85.
RossLS. Diagnosis and treatment of infertile men: A clinical perspective. J Urol1983; 130: 847–54.
86.
WuFCWEdmondPRaabG, Endocrine assessment of the subfertile male. Clin Endocrinol1981; 14: 493–507.
87.
De KretsorDM. Endocrinology of male infertility. Br Med Bull1979; 35: 187–92.
88.
RossLS. Routine hormonal screening of infertile men: Is it worthwhile?J Urol1981; 126: 756–8.
89.
AimanJGriffinJEGazakJM, Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med.1979; 300: 223–7.
90.
SchulsterARossLScommegnaA. Frequency of androgen insensitivity in infertile phenotypically normal men. J Urol1983; 130: 699–701.
91.
WischusenJBakerHWGHudsonB. Reversible male infertility due to congenital adrenal hyperplasia. Clin Endocrinol1981; 14: 571–7.
92.
OjeifoJOWintersSJTroenP. Basal and adrenocorticotrophic hormone stimulated serum 17 hydroxyprogesterone in men with idiopathic infertility. Fertil Steril1984; 42: 97–101.
93.
EblingFJ. Hair. J Invest Dermatol1976; 67: 98.
94.
FarthingMJGMattheiAMEdwardsCRWDawsonAM. Relationship between plasma testosterone and DHT concentration and male facial hair growth. Br J Dermatol1982; 107: 559–64.
95.
MaroulisGB. Evaluation of hirsutism and hyper-androgenaemia. Fertil Steril1981; 36: 273–305.
96.
FerrimanDGallweyJD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab1961; 21: 1440–7.
97.
HatchRRosenfieldRLKimMH, Hirsutism: Implications, aetiology and management. Am J Obstet Gynaecol1981; 140: 815–30.
WiebeRHMorrisCV. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess. Obstet Gynaecol1983; 61: 279–84.
106.
YenSSC. The polycystic ovarian syndrome. Clin Endocrinol1980; 12: 177–208.
107.
VermeulenA. Hirsutism and virilism. Med Int.1984; 12: 501–5.
108.
CunninghamJSkrabanekPLaniganO, Hirsutism and hyperprolactinaemia. Irish Med J1982; 75: 375–6.
109.
SchiavoneFERietschelRLSgoutasDHarrisR. Elevated free testosterone levels in women with acne. Arch Dermatol1983; 119: 799–802.
110.
ChetkowskiRJDefazioJShamonkiI, The incidence of late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab1984; 58: 595–8.
111.
ChrousosGPLoriauxDLMannDL, Late onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Int Med.1982; 96: 143–8.
112.
BirnbaumMDRoseLI. Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynaecol1984; 63: 445–51.
113.
LoboRAGoebelsmannU. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian diseaseAm J Obstet Gynecol.1980; 138: 720–6.
114.
IsmailAAADavidsonDWSoukaAR, The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen cyproterone acetate for therapy. J Clin Endocrinol Metab1974; 39: 81–95.
115.
GivensJRAndersonRNRaglandJB, Adrenal function in hirsutism: Diurnal changes and responses of plasma androstenedione, testosterone, 17-OHP and cortisol, LH and FSH to dexamethasone and ACTH. J Clin Endocrinol Metab1975; 40: 988.
116.
DarleyCRKirbyJDBesserGM, Circulating testosterone, SHBG and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol1982; 106: 517–25.
117.
BaxendalePMJacobsHSJamesVHT. Salivary testosterone: Relationship to unbound plasma test in normal and hyperandrogenic women. Clin Endocrinol1982; 16: 595–603.
118.
BoualloucheABreraultJLFietJ, Evidence for adrenal and/or ovarian dysfunction as a possible aetiology of idiopathic hirsutism. Am J Obstet Gynecol.1983; 147: 57–63.
119.
PugeatMForestMGNisulaBC, Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism. Obstet Gynaecol1982; 59: 46–50.
120.
MooreAMageeFCunninghamS, Adrenal abnormalities in idiopathic hirsutism. Clin Endocrinol1983; 18: 391–9.
121.
CarterGDHollandSMAlaghband-ZadehJ, Investigations of hirsutism: Testosterone is not enough. Ann Clin BioChem.1983; 20: 262–3.
122.
NanjeeMNWheelerMJ. Plasma free testosterone—Is an index sufficient?Ann Clin BioChem.1985; 22: 387–90.
123.
DolinarRBurchWM. Testosterone producing adrenal adenoma in a woman with normal urinary 17-oxosteroid levels. JAMA1983; 250: 2504–5.
124.
SpauldingSWMasudaTOsawaY. Increased 17 β-hydroxysteroid dehydrogenase activity in a masculinizing adrenal adenoma in a patient with isolated testosterone over-production. J Clin Endocrinol Metab1980; 50: 537–40.
125.
SchteingartDEWoodburyMCTsaoHS, Virilising syndrome associated with an adrenal cortical adenoma secreting predominantly testosterone. Am J Med.1979; 67: 140–6.
DeLangeWEPrattJJDoorenbosH. A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadal level in an elderly woman. Clin Endocrinol1980; 12: 21–8.
TrostBN, Virilization of a postmenopausal woman by a testosterone-secreting Leydig cell type adrenal adenoma. Acta Endocrinol1981; 98: 274–82.
130.
HorvathEChalvardJLKovacsK, Leydig-like cells in the adrenal of a woman with ectopic ACTH syndrome. Hum Pathol.1980; 11: 284–7.
131.
BerthelsenJGShakkeboekNE. Gonadal function in men with testis cancer. Fertil Steril1983; 39: 68.
132.
FossaSDKleppOAakvaagA. Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour. Br J Urol1980; 52: 151.
133.
AigingerPKolbeHKühbockK, The endocrinology of testicular germinal cell tumours. Acta Endocrinol1981; 97: 419.
134.
BerthelsenJGEngelholmSMaaseH, Serum testosterone, LH and FSH in patients with testicular cancer before and after radio- and chemotherapy. Scand J Urol Nephrol1983; 17: 287–90.
135.
CutfieldRGBatemanJMOdellWD. Infertility caused by bilateral testicular massess secondary to congenital adrenal hyperplasia (21-hydroxylase deficiency). Fertil Steril1983; 40: 809–14.
136.
OyamaTKudoT. Effect of thiopentone-nitrous oxide anaesthesia and surgery on plasma testosterone levels in human males. Br J Anaesth.1972; 44: 704–6.
137.
NakashimaAKoshiyamaKUozumiT, Effects of general anaesthesia and severity of surgical stress on serum LH and testosterone in males. Acta Endocrinol1975; 78: 258–69.
138.
AonoTKurachiKMiyataM, Influence of surgical stress under general anaesthesia on serum gonadotrophin levels in male and female patients. J Clin Endocrinol Metab1976; 42: 144–8.
139.
SemplePD'aBeastallGHWatsonWS, Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci.1980; 58: 105–6.
140.
DessyprisAKnoppasalmiKAdlecreutzH. Plasma cortisol, testosterone, androstenedione and luteinizing hormone (LH) in a noncompetitive marathon run. J Steroid BioChem.1976; 7: 33–7.
141.
RivarolaMASaexJMMeyerWJ, Metabolic clearance rate and blood production rate of testosterone and androst-4-ene-3, 17-Dione under basal conditions: ACTH and hCG stimulation comparison with urinary production rate of testosterone. J Clin Endocrinol Metab1966; 26: 1208–18.
142.
IrvineWJToetADWilsonKS, The effect of synthetic corticotrophin analogues on adrenocortical, anterior pituitary and testicular function. J Clin Endocrinol Metab1976; 39: 522–9.
143.
BeitinsIZBayardFKowarskiA, The effect of ACTH administration on plasma testosterone dihydrotestosterone and serum LH concentrations in normal men. Steroids1973; 21: 553–3.
144.
GlassARBurmanKDDahmsWT, Endocrine function in human obesity. Metabolism1981; 30: 89–104.
145.
JungR. Endocrinological aspects of obesity. Clin Endocrinol Metab1984; 13: 597–612.
146.
KleyHKDeselaersTReerenboomH. Evidence for hypogonadism in massively obese males due to decresed free testosterone. Horm Metab Res.1981; 13: 639–41.
147.
KleyHSolbachHGMcKinnanJC, Testosterone decrease and oestrogen increase in male patients with obesity. Acta Endocrinol (kbh)1979; 91: 553.
148.
StrainGWSumoffBKreamJ, Mild hypogonadotrophic hypogonadism in obese men. Metabolism1982; 31: 871–5.
149.
KopelmanPGWhiteNPilkingtonTREJeffcoateSL. Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol1980; 12: 363–9.
150.
O'DeaJPKWielandRGHallbergMC, Effect of dietary weight loss on sex hormones binding sex steroids, and gonadotrophins in obese post menopausal womenJ Lab Clin Med.1979; 93: 1004–8.
151.
KopelmanPGWhiteNPilkingtonTREJeffcoateSL. The effect of weight loss on sex steroid secretion and binding in massively obese women. Clin Endocrinol1981; 14: 113–6.
152.
PalmerRLCrispAHMackinnonPCB, Pituitary sensitivity to 50 μg LH/FSH-RH in subjects with anorexia nervosa in acute and recovery stages. Br Med J1975; 1: 179–82.
153.
McNabDHawtonK. Disturbances of sex hormones in anorexia nervosa in the male. Postgrad Med J1981; 57: 254–6.
154.
BaranowskaBZgliczynskiS. Enhanced testosterone in female patients with anorexia nervosa: Its normalisation after weight gain. Acta Endocrinol1979; 90: 328–5.
155.
De KretserDM. The effects of systemic disease on the function of the testis. Clin Endocrinol Metab1979; 8: 487–98.
156.
HoldsworthSAtkinsRCDe KretserDM. The pituitary-testicular axis in men with chronic renal failure. N Engl J Med.1977; 296: 1245–9.
157.
Van KammenEThijssenJHHSchwartzF. Sex hormones in male patients with chronic renal failure. Clin Endocrinol1978; 8: 7–14.
158.
CowdenAERatcliffeWARatcliffeJG, Hyperprolactinaemia in renal disease. Clin Endocrinol1978; 9: 241–8.
159.
LimVSKathpaliaSCFrohmanLA. Hyperprolactinaemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation. J Clin Endocrinol Metab1979; 48: 101–7.
160.
HoldsworthSRDe KretserDMAtkinsRC. A comparison of haemodialysis and transplantation in reversing the uraemic disturbance of male reproductive function. Clin Nephrol1978; 10: 146–50.
161.
BoydenTWParmenterRW. Effects of ethanol on the male hypothalamic-pituitary-gonadal axis. Endocrine Rev1983; 4: 389–5.
162.
Van ThielDHLesterR. The effect of chronic alcohol abuse on sexual function. Clin Endocrinol Metab1979; 8: 499–510.
163.
GreenJRBGobleHLEdwardsCRW, Reversible insensitivity to androgens in men with untreated gluten enteropathy. Lancet.1977; 1: 280–2.
164.
FarthingMJGReesLHEdwardsCRW, Male gonadal function in coeliac disease. 2. Sex hormones. Gut1983; 24: 127–35.
165.
WhitbyRMGordonRDBlairBR. The endocrine effects of vasectomy: A prospective five year study. Fertil Steril1979; 31: 518–20.
166.
NieschlagEFreischemCW. Androgen therapy in hypogonadism and infertility. In: BainJSchillWBSchwarzsteinL, eds. Treatment of Male Infertility. Berlin: Springer-Verlag, 1982; 103–15.
167.
SnyderPN. Clinical use of androgens. Annu Rev Med.1984; 35: 207–17.
168.
MaiseyNMBinghamJMarksV, Clinical efficacy of testosterone undecanoate in male hypogonadism. Clin Endocrinol1981; 14: 625–9.
169.
CantrillJADavisPLargeDM, Which testosterone replacement therapy?Clin Endocrinol1984; 21: 97–107.
170.
SaezJMForestMG. Kinetics of human chorionic gonadotrophin-induced steroidogenic response of the human testis. I. Plasma testosterone: Implications for human chorionic gonadotrophin stimulation test. J Clin Endocrinol Metab1979; 49: 278–83.
171.
SmalsAGHPietersGFFMDickC, Dissociated responses of plasma testosterone and 17-hydroxyprogesterone to single or repeated human chorionic gonadotrophin administration in normal men. J Clin Endocrinol Metab1980; 50: 190–3.
172.
BagshaweKDScarleFWassM. Human chorionic gonadotrophin. In: GrayCHJamesVHT, eds. Hormones in Blood3rd edn, Vol. 1. New York: Academic Press, 1979; 363–409.
173.
ForestMGDavidMLecogO, Kinetics of the hCG induced steroidogenic response of the human testis. III. Studies in children of plasma levels of testosterone and hCG rationale for testicular stimulation test. Paediatr Res.1980; 14: 819–24.
174.
TapanainenJMartkainenHDunkelL, Steroidogenic response to a single injection of hCG in pre and early pubertal cryptorchid boys. Clin Endocrinol1983; 18: 355–62.
175.
ForestMG. Pattern of the response of testosterone and its precursors to human chorionic gonadotrophin stimulation in relation to age in infants and children. J Clin Endocrinol Metab1979; 49: 132–7.
176.
KnorrDBeckmannDBidlingmaierF, Plasma testosterone in male puberty. Acta Endocrinol1979; 90: 365–71.
177.
KruytNRollandR. Cortisol, 17-OH progesterone and androgen responses to a standardised ACTH-stimulation in different stages of the normal menstrual cycle. Acta Endocrinol1982; 100: 427–33.
178.
DerineATrouve-BlanquiEOliverC, Influence of corticotrophin on plasma testosterone in normal women. Acta Endocrinol1980; 94: 201–3.
179.
MortimerCHBesserGMMcNeillyAS, Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J1973; iv: 73–7.
SnyderPJRudensteinRSGardnerDF. Repetitive infusion of gonadotrophin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism. J Clin Endocrinol Metab1979; 48: 864–8.
182.
YoshimotoYMorideraKImuraH. Restoration of normal pituitary gonadotrophin reserve by administration of luteinizing-hormone-releasing hormone in patients with hypogonadotrophic hypogonadism. N Engl J Med.1975; 292: 242–5.
183.
IsmailAAA. Disorders of gonadal function in the male. In: Biochemical Investigations in Endocrinology. New York: Academic Press, 1981; 162–75.
184.
LambertonRPJacksonIMD. Investigation of hypothalamic-pituitary disease. Clin Endocrinol Metab1983; 12: 509–34.
185.
BardinCWPaulsenCA. The testes. In: WilliamsRH, ed. Textbook of Endocrinology. London: WB Saunders, 1981; 293–354.
186.
KentJRHillMParlowAFBischoffAJ, Oestrogenic suppression of the pituitary-gonadal axis. Clin Pharmacol Ther1972; 13: 144.
187.
SchwarzSBoydJ. Interference of Danazol with the radioimmunoassay of steroid hormones. J Steroid BioChem.1982; 16: 823–6.
HanningRV. Danazol and its principal metabolites interfere with the binding of testosterone, cortisol and thyroxine by plasma protein. Clin Chem.1982; 28: 696.
190.
JeffcoateWJMatthewsRWEdwardsCRWFieldLHBesserGM. The effect of cyproterone acetate on serum testosterone, LH, FSH and prolactin in male sexual offenders. Clin Endocrinol1980; 13: 189–95.
191.
KauliR, Cyproterone acetate in treatment of precocious puberty. Arch Dis Child1976; 51: 202–8.
192.
OlivoJSouthernALGordonGGTochimotoS. Studies of the protein binding of testosterone in plasma in disorders of thyroid function: Effect of therapy. J Clin Endocrinol1970; 31: 539–45.
193.
RidgewayECLongscopeCMaloofF. Metabolic clearance and blood production rates of oestradiol in hyperthyroidism. J Clin Endocrinol Metab1975; 41: 491–7.
194.
RuderHCoriolPMahoudeauJARossGTLipsettMB. Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab1971; 33: 382–7.
195.
NakagawaKObaraTMatsubaraMKuboM. Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males. J Clin Endocrinol1982; 17: 345–52.
196.
CarterJNTysonJETolisGVan VlietSFaimanMDFriesenHG. Prolactin secreting tumours and hypogonadism in 22 men. N Engl J Med.1978; 299: 847–52.
197.
SirisSGSirisESVan KammenDP. Effects of dopamine blockade on gonadotrophin and testosterone in men. Am J Psychiatr1980; 137: 211–4.
198.
BrownWALaughrenTPWilliamB. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men. Arch Gen Psychiatr1981; 38: 1270–2.
199.
MessinaMManieriCBiffignandiPMassucchettiCNoviREMolinattiGM. Antiandrongenic properties of spironolactone. Clinical trial in the management of female hirsutism. J Endocrinol Invest1983; 6: 23–7.
200.
SpandriPGangemiMNardelliGB, Testosterone, 17KS, oestradiol, FSH-LH variation and hirsutism modification during spironolactone therapy. Clin Exp Obstet Gynaecol1984; 11: 49–54.
WangCLaiCLLaiXCYeungKK. Effect of cimetidine on gonadal function in man. Br J Clin Pharmacol1982; 13: 791–4.
203.
PedanNRBoydEJSBrowningMCKSaunderJHBBWormsleyKG. Effect of two histamine H2 receptor blocking drugs on basal levels of gonadotrophins, prolactin, testosterone and oestradiol-17β-during treatment of duodenal ulcer in male patients. Acta Endocrinol1981; 96: 564–8.
204.
SavarinoVGiustiMMansiCMarugoMDelitateGCelleG. Ranitidine and testosterone secretion in man. Br J Clin Pharmacol1983; 15: 579.
205.
BarraggJMMakinHLJTraffordDJHScottDF. Effects of anticonvulsants on plasma testosterone and SHBG levels. J Neurol Neurosurg Psychiatr1978; 41: 913–4.
206.
Dani-HaeriJOxleyJ. Reduction of free testosterone by antileptic drugs. Br Med J1982; 284: 85–6.
207.
TooneBKWheelerMFenwickPBC. Sex hormone changes in male epileptics. Clin Endocrinol1980; 12: 391–5.
208.
TooneBKWheelerMNanjeeM, Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics. J Neurol Neurosurg Psychiatr1982; 46: 824–6.
209.
PukkinenMOMaepaaJ. Decrease in serum testosterone concentration during treatment with tetracycline. Acta Endocrinol1983; 103: 269–2.
210.
Nocke-FinckLBreuerHReimersD. Wirkung von Rifampicin und Streptomycin auf die Konzentrationen von Testosteron und Cortisol im Blutt von Männern. J Clin Chem Clin BioChem.1980; 18: 897–9. (In German with English abstract.).
211.
KumarRBiggartJDMcEvoyJMcGowenM. Cyclophosphamide and reproductive function. Lancet.1972; i: 1212–4.
212.
ForestMGDe PerettiEBertrandJ. Hypothalamic-pituitary-gonadal relationships in man from birth to puberty. Clin Endocrinol1976; 5: 551–69.
213.
GabriloveJLSemanATSabetR, Virilizing adrenal adenosine with studies on the steroid content of the adrenal venous effluent and a review of the literature. Endocrinol Res.1981; 2: 462–70.